AONM’s Cancer Webinar Series is a series of educational videos to help practitioners and patients make better informed treatment choices
1. Maintrac® is not intended to be used as a diagnostic or screening approach. It may be used for tracking the progression or remission of tumours of epithelial origin through its detection of circulating epithelial tumour cells (CETCs) in the blood. The approach has multiple applications, including helping to inform clinical judgment in the provision of functional or integrative support for patients or clients. If Maintrac® to be used to inform cancer treatment directly, or to monitor the interaction of chemotherapeutic agents with CETCs or CSCs (circulating stem cells), the tests must be overseen by a registered medical practitioner or oncologist.
2. These videos are for educational and informational purposes only. They are not intended to be used by doctors, other practitioners, patients or clients to diagnose, treat or prevent any disease. Cancer diagnosis, treatment or advice in connection with treatment can only be given by a registered medical practitioner or oncologist.
Chris Woollams, M.A. (Oxon); Biochemistry and founder of CancerActive: Rebuilding the Microbiome: A Vital Approach in the Treatment of Cancer and Chronic Illness.
Professor Dr. Katharina Pachmann : Apoptosis efficency of natural agents and an overview of therapy-relevant characteristics of circulating cancer cells.
Chris Woollams, M.A. (Oxon); Biochemistry and founder of CancerActive: The Benefits of Complementary and Integrative Medicine in the Field of Oncology
Professor Dr. Katharina Pachmann: The Science and Clinical Utility of CTCs as a Tool to Monitor the Effectiveness of Therapy
In May 2017 Dr. Armin Schwarzbach gave a presentation at an AONM conference on “Viruses and Cancer”.